Top Story

Nivolumab shows promise for advanced hepatocellular carcinoma

May 29, 2015

CHICAGO — Nivolumab appeared safe and effective for the treatment of patients with advanced hepatocellular carcinoma, according to interim study results presented at the ASCO Annual Meeting.

The responses observed with nivolumab (Opdivo, Bristol-Myers Squibb) — a programmed cell death-1 (PD-1) antibody — also appeared durable, results showed.

Tanguy Seiwert, MD Meeting News Coverage

Pembrolizumab demonstrates 'remarkable' efficacy in advanced head and neck cancers

May 29, 2015
CHICAGO — The anti–PD-1 antibody pembrolizumab demonstrated strong activity in patients with recurrent or metastatic head and neck squamous cell carcinoma…
Meeting News CoveragePerspective

Mismatch repair deficiency predicts response to pembrolizumab in several cancer types

May 29, 2015
CHICAGO — Mismatch repair deficiency may be the first genomic marker to predict how patients with cancer will respond to immune checkpoint blockade with the…
Meeting News Coverage

Post-hospital prophylaxis could reduce risk for venous thromboembolism, death after lung resection

May 29, 2015
The incidence of post-operative venous thromboembolism following oncologic lung resections and after discharge is significant, despite guidelines directing prophylaxis…
In the Journals

CDC: Cancer screening rates remain below Healthy People 2020 targets

May 29, 2015
 The number of adults in the U.S. who underwent the recommended screening tests for breast, colorectal and cervical cancers in 2013 fell below the targets set by…
More News Headlines »
CME
Hematology Oncology Case Consults

Diagnosis and Management of Hemophilia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of the patient with hemophilia supplemented with a case…
More »
Meeting News Coverage Video
VIDEO: Updates in prostate cancer treatment options

VIDEO: Updates in prostate cancer treatment options

May 5, 2015
Robert S. DiPaola, MD, director of Rutgers Cancer Institute of New Jersey, discusses various forms of prostate cancer…
More »
CME CNE
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
morganatic-roan